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Aim:  The  aim  of this  study  was  to assess  the  effectiveness  of the two-part  semi-rigid  oral  appliance,
Silensor® (Erkodent,  Tuttlingen,  Germany)  which  prevents  the  mandible  from  retracting  during  mouth
opening.
Materials  and  methods:  Ten  patients  with  mild  or moderate  obstructive  sleep  apnea  (2 males  and  8
females;  mean  age  = 62.5  ±  10.0  years)  were  recruited  and  lateral  cephalometric  radiographs  were  taken.
The  patients  underwent  polysomnography  before  and  after  3  months  of receiving treatment  with  the
Silensor®.  The  relationship  between  the  improvement  in the  polysomnographic  variables  after  the  ther-
apy  and  the  cephalometric  features  was  analyzed.
Results: A signiﬁcant  difference  was  observed  in  the  apnea–hypopnea  index  after  3  months  of  Silensor®
therapy  (1st  (baseline),  17.1  ± 5.5;  2nd  (therapy  of  Silensor®), 11.0  ± 7.2,  p = 0.011).  Furthermore  there
was  a  signiﬁcant  positive  correlation  between  the  improvement  in  the degree  of slow  wave  sleep (%)
and  the  mandibular  plane  angle  (R  =  0.662,  p = 0.037),  as  well  as between  the  improvement  in  degree  of
slow  wave  sleep  (%)  and  the  lower  face height  (R  =  0.845,  p = 0.002).  A  signiﬁcant  negative  correlation  was
observed  between  the improvement  in  degree  of  sleep  efﬁciency  (%) and  the  soft palate  area  (R  = −0.809,
p  = 0.005).
Conclusion: These  results  suggested  that  keeping  the  nasopharyngeal  airway  space  during  mouth  opening
improves  apnea–hypopnea  index  of  some  patients  with  mild  or  moderate  obstructive  sleep  apnea  and
quality  of  sleep  in  obstructive  sleep  apnea  patients  with  a  long  lower  face  height  and  a  small  soft  palate.
 Japan© 2012
. Introduction
Obstructive sleep apnea (OSA) is caused by narrowing of the
haryngeal space and a sleep-induced loss of muscle tone. Nasal
ontinuous positive airway pressure (nCPAP) has become a stan-
ard treatment of OSA, while mandibular advancement splints
MASs) have been used for patients with mild to moderate OSA
r those who were unable to tolerate nCPAP. By advancing the
andible and stretching the tongue, MASs enlarge the pharyngeal
irway space. Most of the MASs take a monobloc form, but a rigid
AS puts a strain on the temporomandibular joints [1]. On the other
and, a two-part and semi-rigid oral appliance (OA) produced less
iscomfort and obtained an adequate result in compliance [2] in
pite of an inferior effectiveness compared to a rigid MAS  [3]. The
∗ Corresponding author. Tel.: +81 92 801 1011; fax: +81 92 801 1044.
E-mail  address: george@minf.med.fukuoka-u.ac.jp (G. Umemoto).
348-8643/$ – see front matter ©  2012 Japanese Stomatological Society. Published by Els
oi:10.1016/S1348-8643(12)00028-6ese Stomatological Society. Published by Elsevier Ltd. All rights reserved.
characteristic of the two-part semi-rigid OA, Silensor® (Erkodent,
Tuttlingen, Germany) is to advance the mandible during mouth
opening and return the mandible near the occlusal position during
mouth closing. Therefore, avoiding the mandible retracting dur-
ing opening is thought to be the main treatment mechanism of
Silensor®.
However, there were not precise criteria for the selection of
an appliance design and information as to which patients may be
expected to beneﬁt from Silensor® was not available. Cephalomet-
ric features associated with a good airway response to protrusion
are a reduced lower facial height, a low mandibular plane angle, and
a high hyoid position [4–6], and the perpendicular distance from
the hyoid bone to the mandibular plane is an important predictor of
improvement in the apnea–hypopnea index (AHI) by MAS  therapy
[6,7]. The aims of the present study were to assess the effectiveness
of Silensor®, analyzing the change in sleep quality before and after
the therapy and the relationship between the improvement in the
degree of the polysomnographic variables after the therapy and the
evier Ltd. All rights reserved.
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Fig. 1. Variables used for cephalometric analysis. The maxillary plane horizontal (S,
center of Sella turcica to N, most anterior point of frontonasal suture), mandibular
plane  (Go, the left end of lower jaw border line to Me,  the right end), point ‘A’ is
the anterior point of the maxillary apical base, and point ‘B’ is the mandibular apical
base and anterior nasal spine (ANS). The mandibular plane angle, is formed from the0 G. Umemoto et al. / Oral Scie
ephalometric features, and to demonstrate which patients may  be
uitable for Silensor® therapy.
. Patients and methods
.1.  Participants
Thirty-four patients were diagnosed as having mild or moderate
SA (AHI, 5–30/h) which was not susceptible to nCPAP treatment
y pulmonologists after polysomnography (PSG) at the Department
f Respiratory Medicine, Faculty of Medicine, Fukuoka University,
etween July 2007 and March 2010. They were referred to our
epartment for the purpose of receiving treatment with OA and
dentulous patients or those with severe periodontic or temporo-
andibular joint disease were excluded. Ten participants (2 males
nd 8 females; mean age = 62.9 ± 10.0 years; age range, 38–76
ears) of the thirty-four patients wore Silensor® for 3 months and
nderwent second follow-up PSG (Table 1). The participants had a
ean body mass index (BMI) of 23.8 ± 3.9 kg/m2 and a mean body
eight of 58.0 ± 6.9 kg. Two patients had type 2 diabetes melli-
us and ﬁve patients showed cardiovascular diseases. All of the
articipants started the Silensor® therapy with no nCPAP therapy.
nformed consent was obtained from all participants.
.2. Facial morphology by cephalogram analysis
Lateral cephalometric radiographs were taken with the teeth
n occlusion and following a standardized procedure. The maxil-
ary plane horizontal (S, center of Sella turcica to N, most anterior
oint of frontonasal suture), mandibular plane (Go, the left end of
ower jaw border line to Me,  the right end), point ‘A’ which is the
nterior point of the maxillary apical base, and point ‘B’ which is
he mandibular apical base and anterior nasal spine (ANS) were
dentiﬁed. The mandibular plane angle, which is formed from the
ntersection of the mandibular plane and the Frankfurt plane (Po,
he highest point of the external acoustic meatus to Or, the most
nferior point of the infraorbital rim), position of the maxilla (SNA
ngle), position of the mandible (SNB angle), lower face height
ANS-Me/N-Me ratio), hyoid to mandible plane (hyoid bone vertical
osition relative to mandible plane), tongue area (bounded by dor-
um conﬁguration of tongue surface and lines that connect tongue
ip, retrognathion, hyoidale, and base of epiglottis) and soft palate
rea (starts and ends at posterior nasal spine through most infe-
ior tip of soft palate) [8] were measured by cephalogram analysis
Fig. 1). A high mandibular plane angle, a low SNA angle, and a high
ower face height were regarded as a steep mandibular plane and
 posteriorly positioned maxilla, or a “long face” as it is commonly
alled. In addition to the variables, a low SNB angle which indicates
 retractive mandible, a low hyoid position, a large tongue propor-
ion, and a long thick palate were thought to be high risk factors for
 decrease in oropharyngeal airway space or OSA [4].
.3.  The two-part semi-rigid OA, Silensor®
The two-part, semi-rigid OA, Silensor®, made of transparent
ard polyethylene materials 2 mm thick, was used for the study
Fig. 2). Upper and lower elements were joined by plastic straps
3 mm or 24 mm long running from the upper canine to the
ower molar regions. During mandibular closing, Silensor® was so
djusted that the mandible could return to the position, in which
ertical dimension was increased by approximately 4 mm  by the
plint material from the occlusal position. This orientation of the
onnectors permitted only forward movement of the mandible
uring approximately 4–8 mm mouth opening, and avoided the
eduction of the airway normally associated with mandibular open-
ng. Participants were instructed on how to ﬁt the Silensor® andintersection of the mandibular plane and the Frankfurt plane (Po, the highest point
of the external acoustic meatus to Or, the most inferior point of the infraorbital rim),
position of the maxilla (SNA angle), position of the mandible (SNB angle).
it was worn nightly for 3 months. After 3 months of receiving
treatment, they were asked about the existence of side effects and
improvement of daytime sleepiness using the Epworth Sleepiness
Scale (ESS) [9], sound sleep, and feelings on waking up.
2.4.  Polysomnography
Standard overnight PSG included continuous monitoring using
central electroencephalograms, electrooculograms, submental and
anterior tibial electromyograms, and electrocardiograms with con-
ventional leads. Airﬂow was  monitored using oral and nasal
thermistors, and respiratory effort was  measured by respi-
ratory inductance plethysmography with transducers placed
around the chest and abdomen. Oxyhemoglobin saturation was
recorded continuously using a pulse oximeter. All variables were
recorded continuously using Rembrandt (Medcare, Amsterdam,
The Netherlands). Apnea was  deﬁned as the cessation of airﬂow
for at least 10 s, and hypopnea was deﬁned as a 50% or greater
reduction in airﬂow for at least 10 s with oxygen desaturation of
more than 3%. All recordings were scored directly on the screen by
a RPSGT (Registered Polysomnographic Technologist) and a certi-
ﬁed physician of sleep medicine, Japanese Society of Sleep Research
using the standard criteria of Rechtshaffen and Kales [10,11].
2.5.  Change in sleep quality between before and after the
Silensor® therapy
To  assess the change in sleep quality by Silensor® therapy, two
sets of polysomnographic variables were obtained before and after
3 months of receiving treatment with Silensor® and the results
obtained from each time point were compared. Polysomnographic
variables included the AHI, lowest SpO2, arousal index, snoring
index, periodic leg movement (PLM) index, sleep efﬁciency (SE),
sleep ratio (stages 1–4 and REM), and slow wave sleep percent
G. Umemoto et al. / Oral Science International 9 (2012) 49– 54 51
Table  1
Clinical features of the 10 obstructive sleep apnea participants.
Sex Age (years) Body mass
index (kg m−2)
Mandibular
plane angle
(deg.)
SNA
(deg.)
SNB
(deg.)
ANB
(deg.)
Lower  face
height (%)
Hyoid to
mandible plane
(mm)
Tongue area
(mm2)
Soft palate area
(mm2)
Case 1 F 38 23.6 33.7 85.8 83.6 2.2 58.5 13.3 1754 168
Case  2 M 63 19.1 27.3 79.5 79.6 −0.1 56.9 7.0 2120 202
Case  3 F 60 22.1 45.6 80.1 77.8 2.3 58.6 10.5 1860 164
Case  4 M 62 22.4 34.2 78.9 80.2 −1.3 57.1 17.9 2180 216
Case  5 F 66 30.1 32.3 79.7 75.5 4.2 57.2 9.5 1974 173
Case  6 F 66 23.5 24.5 79.7 77.7 2.0 58.0 0 2109 153
Case  7 F 67  29.1 29.1 78.4 79.4 −1.0 53.6 15.5 1905 262
Case  8 F 76 26.5 28.3 78.7 77.5 1.2 56.0 17.4 1791 162
Case  9 F 58 23.9 24.4 83.1 81.5 1.6 57.4 5.7 2100 155
Case10  F 69 18.1 30.9 72.5 70.4 2.1 58.7 0 2137 172
Mean  62.5 23.8 31.0 79.6 78.3 1.3 57.2 9.7 1993 182.7
(SD) (10.0) (3.9) (6.2) (3.4) (3.6) (1.7) (1.5) (6.5) (156.5) (34.4)
, semi
o
i
o
t
s
s
2
g
r
g
S
p
3
o
w
S
p
b
r
r
S
m
d
a
i
l
was a signiﬁcant difference in the ESS before and after the Silensor®
therapy (6.3 ± 2.4 and 4.1 ± 1.7, respectively, p = 0.013). During the
Silensor® therapy, seven participants (70%) felt as though they wereFig. 2. The two-part
f total sleep time. The improvements in degree of AHI, arousal
ndex, and snoring index were calculated by subtracting the sec-
nd value obtained after Silensor® therapy from the ﬁrst value and
he improvements in degree of lowest SpO2, SE, and slow wave
leep (%) were calculated by subtracting the ﬁrst value from the
econd value.
.6.  Data analysis
Paired  t-tests were used to compare the two sets of polysomno-
raphic variables.
Pearson correlation coefﬁcient was used to measure linear
elationships between the improvement in degree of polysomno-
raphic variables and cephalometric variables.
Statistical data were analyzed using the Statistic Package for
ocial Science (IBM SPSS, Armonk, NY, USA) for Windows and
 < 0.05 was considered signiﬁcant.
.  Results
There was no signiﬁcant difference between the body weight
btained before and after 3 months of receiving treatment
ith Silensor® [1st (baseline), 58.0 ± 6.9 kg; 2nd (therapy with
ilensor®), 58.0 ± 7.0 kg, p = 0.967]. The body weight of the partici-
ants did not change more than 2 kg during the 3 months.
A signiﬁcant difference was observed in the AHI obtained
efore and after the Silensor® therapy (17.1 ± 5.5 and 11.0 ± 7.2,
espectively, p = 0.011) (Table 2). There were three (30%) complete
esponders (AHI with Silensor® < 5), six (60%) responders (AHI with
ilensor® 5), and four (40%) non-responders (deﬁned as improve-
ent in AHI of <25%) (Fig. 3). However, there was no signiﬁcant
ifference in the other polysomnographic variables obtained before
nd after the treatment.
A  signiﬁcant positive correlation was observed between the
mprovement in degree of slow wave sleep (%) and the mandibu-
ar plane angle (R = 0.719, p = 0.019), as well as between the-rigid OA, Silensor® .
improvement in degree of slow wave sleep (%), and the lower face
height (R = 0.845, p = 0.002) (Fig. 4). Furthermore, a signiﬁcant cor-
relation was observed between the improvement in degree of sleep
efﬁciency (%) and the lower face height (R = 0.742, p = 0.014), as
well as between the improvement in degree of sleep efﬁciency (%)
and the soft palate area (R = −0.809, p = 0.005) (Fig. 5). No signif-
icant correlation was  observed between the other improvements
in degree of other polysomnographic variables, including AHI, and
the cephalometric variables (Table 3).
After 3 months of the Silensor® therapy, no participants
reported discomfort with Silensor® or side effects with the
Silensor® therapy, including temporomandibular pain or occlusion
change in the morning. Five of the ten participants (50%) reported
improvement in daytime sleepiness after the treatment and thereFig. 3. Change in apnea–hypopnea index between the two points.
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Table 2
Changes in polysomnographic variables between the two time points.
1st mean ± SD
(range)
2nd  mean ± SD
(range)
p-value
Apnea–hypopnea index (/h) 17.1 ± 5.5 (11.2–30.2) 11.0 ± 7.2 (4.0–22.7) 0.011*
Lowest SpO2 (%) 85.4 ± 8.8 (72–98) 88.5 ± 5.8 (79–96) 0.155
Arousal  index (/h) 18.8 ± 6.7 (11.1–31.5) 17.5 ± 9.3 (6.7–39.2) 0.520
Snoring  index (/h) 21.9 ± 10.4 (7.2–38.3) 23.1 ± 11.5 (3.3–40.4) 0.762
Periodic  leg movement index (/h) 9.2 ± 17.2 (0–45.3) 9.9 ± 14.4 (0–37.9) 0.709
Sleep  efﬁciency (%) 77.0 ± 9.7 (59.2–94.3) 76.1 ± 12.2 (49.5–95.8) 0.731
Stage  1 (%) 17.7 ± 6.1 (6.5–25.7) 19.7 ± 7.0 (11.7–35.1) 0.502
Stage 2 (%) 57.6 ± 6.2 (46.7–65.4) 58.5 ± 8.1 (40.8–67.1) 0.773
Slow  wave sleep (%) 2.0 ± 1.8 (0.0–5.7) 2.9 ± 3.0 (0–4.7) 0.376
Rapid  eye movement (%) 20.1 ± 7.4 (9.4–33.3) 18.9 ± 5.6 (10.4–27.8) 0.562
* Sleep stage was  calculated as a percentage (%) of total sleep time.
Table  3
Relationship between improvement in degree of polysomnographic variables and cephalometric variables.
Apnea–hypopnea index (/h) Lowest SpO2 (%) Arousal index (/h) Snoring index (/h) Sleep efﬁciency (%) Slow wave sleep (%)
Body mass index (kg m−2) n.s. n.s. n.s. n.s. n.s. n.s.
Mandibular  plane angle (deg.) n.s. n.s. n.s. n.s. n.s. R = 0.662
p = 0. 037*
SNA (deg.) n.s. n.s. n.s. n.s. n.s. n.s.
SNB  (deg.) n.s. n.s. n.s. n.s. n.s. n.s.
ANB  (deg.) n.s. n.s. n.s. n.s. n.s. n.s.
Lower  face height (%) n.s. n.s. n.s. n.s. R = 0.742
p = 0.014*
R = 0.845
p = 0.002*
Hyoid to mandible plane (deg.) n.s. n.s. n.s. n.s. n.s. n.s.
Tongue  area (mm2) n.s. n.s. n.s. n.s. n.s. n.s.
2 n.s. 
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lSoft  palate area (mm ) n.s. n.s. 
* p ≤ 0.05.
leeping better, and four patients (40%) indicated that they were
aking up feeling better.
.  Discussion
There was no signiﬁcant difference in the polysomnographic
ariables,  except for AHI, obtained before and after the Silensor®
herapy. These results of a low improvement in degree of
olysomnographic variables in this study compared with the
esults of other studies [3,6,7,12] may  be caused by the small num-
er of participants which is the most obvious limitation in the study.
hese ten cases include three cases whose data for AHI and slow
ave sleep (%) were not improved after the Silensor® therapy.
owever, it was difﬁcult to detect characteristics to distinguish
he responders and the non-responders to the Silensor® therapy
ig. 4. Correlation between improvement in degree of slow wave sleep (%) and
ower  face height.n.s. R = −0.809
p = 0.005*
n.s.
from this study because of no signiﬁcant difference in lowest SpO2,
arousal index, or snoring index particularly which may make clear
the treatment mechanism of Silensor® to improve AHI.
The  results of a signiﬁcant correlation between the improve-
ment in degree of slow wave sleep (%) and the mandibular plane
angle, as well as between the improvement in degree of slow wave
sleep (%) and the lower face height also suggest that Silensor®
improves the quality of sleep in OSA patients with a “long face”
who have a larger mandibular plane angle than 30.7 degrees (calcu-
lated using a regression line; mean value in Japanese: 26.25 ± 6.34
degrees) or a larger lower face height than 57.1% (calculated using
the regression line in Fig. 4; mean value in Japanese: 57.3 ± 0.74%).
Furthermore, because of the signiﬁcant correlation between the
improvement in degree of sleep efﬁciency (%) and the lower face
height, Silensor® may  improve the quality of sleep in OSA  patients
who have a larger lower face height than 57.6% (calculated using
Fig. 5. Correlation between improvement in degree of sleep efﬁciency (%) and soft
palate area.
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aig. 6. The lateral cephalometric radiographs of an obstructive sleep apnea patient
he mouth (right).
 regression line; mean value in Japanese: 57.3 ± 0.74%). From
hese ﬁndings, the Silensor® therapy may  prevent the mandible
f “long face” individuals from rotating downwards and back in the
upine position. Özdemir et al. [13] described that an increase in
onial angle results in reduced protrusor mechanical efﬁciency of
enioglossus muscle and relative retrodisplacement of the tongue
hich are associated with consequent chronic mouth breathing.
heir suggestion indicates the possibility that using Silensor® for
atients with larger mandibular plane angle may  prevent retrodis-
lacement of the tongue keeping the nasopharyngeal airway space,
ven if the patient is a mouth open sleeper.
Previous studies [14,15] reported that OSA patients had posteri-
rly rotated mandibles and longer lower facial height. Battagel et al.
4] indicated that a reduced lower facial height or low mandibu-
ar plane angle was associated with a good airway response to
andibular protrusion. Based on similar results, Liu et al. [16]
onsidered that a mandibular repositioner was likely to make the
andible of a patient with a steep mandibular angle rotate clock-
ise so that the genioglossus and hyoid musculature tends to
e closer to the posterior pharyngeal wall. However, these stud-
es used monobloc form MASs, accordingly the opposite ﬁndings
n the favorable craniofacial features between the previous stud-
es and our study which used the two-part semi-rigid OA are
cceptable. Differently from most monobloc form MASs, the main
reatment mechanism of Silensor® is thought to avoid the mandible
etract during mouth opening while maintaining the mandible near
he occlusal position during mouth closing. The compact form of
ilensor® makes possible the maintenance of the mandible near
he occlusal position during mouth closing and the advantage may
e more effective for quality of sleep of patients with a “long face”
y preventing mandible from rotating clockwise.
The lateral cephalometric radiographs of an OSA patient that
ere taken without Silensor® closing the mouth and with Silensor®
pening the mouth showed slight changes in position of the
andible and in size of the nasopharyngeal airway space (Fig. 6).
ith Silensor® opening the mouth, the mandible moved forward mm at the most and the area of the nasopharyngeal airway space
howed an increase by approximately 10%. This changing range
f area made us consider that Silensor® kept the nasopharyngeal
irway space during sleep.were taken without Silensor® closing the mouth (left) and with Silensor® opening
Skinner et al. [7], using a rigid but titratable MAS  indicated
the importance of distance from the hyoid bone to the mandible
in order to predict the treatment outcome and the helpfulness of
supine cephalometry. Therefore, although there was no signiﬁcant
correlation between the improvement in degree of polysomno-
graphic variables and the distance from hyoid bone to mandible
plane, to measure the distance from the hyoid bone to the mandible
using the cephalometric ﬁlms taken in the standing position in this
study may be meaningless. On the other hand, their result of no
cephalometric measure except for the distance from the hyoid bone
to the mandible associated with an improvement in polysomno-
graphic variables was  not consistent with our result. There are no
precise criteria for deciding a MAS  design on facial morphology and
the difference in results among studies using various types of MAS
may  suggest differences in the susceptible range due to the MAS
design. To conﬁrm this possibility, it is necessary to examine and
compare the two  types of OA using an increased sample size.
Considering  the treatment mechanism of Silensor® to maintain
the mandible near the occlusal position during mouth closing and to
prevent mandible from rotating clockwise, Silensor® may be suit-
able for OSA patients with mouth breathing. Okawara et al. [17]
suggested that gradual anterior titration of mandibular position
reducing the nasal resistance would give OSA patients therapeu-
tic effects, while Zeng et al. [18] reported higher levels of nasal
airway resistance which is associated with mouth breathing may
negatively affect treatment outcome with MAS. There is some pos-
sibility that Silensor® is more effective for OSA patients with mouth
breathing, and our results showed a signiﬁcant negative correlation
between the improvement in degree of sleep efﬁciency (%) and the
soft palate area. Nasal resistance is related to transpalatal resistance
and larger soft palate was  mentioned as a factor to induce a poor
treatment response with MAS  seen in OSA patients [19]. The ﬁnding
concerning the area of soft palate in our study was consistent with
the results of many previous studies using MASs. A larger sample
size of patients would be required in order to assess the efﬁcacy of
Silensor® in managing OSA patients with mouth breathing.Lowe et al. [20] reported the difference in craniofacial and upper
airway structure between genders and Battagel et al. [21] men-
tioned a greater amount of mandibular protrusion in females than
males. Different from most previous OSA studies, in our study, the
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[
[
[4 G. Umemoto et al. / Oral Scie
umber of female participants was larger than that of males and
hat seven of the eight female participants were postmenopausal.
oung et al. [22] indicated that the menopausal transition increases
he risk for sleep-disordered breathing, independent of other con-
ounding factors. These gender or age differences in our study may
nﬂuence differences in ﬁndings to previous studies.
According to the participants’ subjective reaction to Silensor®
herapy, most participants seemed to be satisﬁed with the ther-
peutic efﬁcacy concerning daytime sleepiness, sleeping, and the
aking up feeling, and showed few side effects. From these ﬁnd-
ngs, good compliance with Silensor® therapy in the short-term is
xpected. Previous studies [23,24] reported a high prevalence of
nitial side effects with MAS  therapy, including temporomandibu-
ar pain (69–41%) or occlusion change (69–32%), but they also
escribed that no side effect disturbed the continuation of treat-
ent in the long term. On the other hand, the most common reason
iven for stopping use of OA was reported to be discomfort (52%)
2]. Considering the long-term continuation of OA treatment, it is
till important to reduce the temporomandibular joint or occlusal
iscomfort arising from use of OAs. The process to make Silensor® is
ore convenient than the other type of MAS, therefore, Silensor® is
onsidered to have a good performance by selecting mild or moder-
te OSA patients who are susceptible to the treatment on the basis
f cephalometric analysis.
.  Conclusion
A  signiﬁcant difference was observed in AHI after 3 months of
herapy using the two-part semi-rigid OA, Silensor®. Furthermore
here was a signiﬁcant positive correlation between the improve-
ent in degree of slow wave sleep (%) and the mandibular plane
ngle, as well as between the improvement in degree of slow wave
leep (%) and the lower face height. A signiﬁcant negative correla-
ion was also observed between the improvement in degree of sleep
fﬁciency (%) and the soft palate area. These results suggested that
eeping the nasopharyngeal airway space during mouth opening
mproves AHI of some patients with mild or moderate OSA and has
he potential of making the quality of sleep better in OSA patients
ith a long lower face height and a small soft palate.
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